Firm Record

Central Admixture Pharmacy Services, Inc. (CAPS) findings history

52 findings from 5 inspection documents published by regulators. Each row below says what its date means.

US FDA 2024-01-17 ~ 2024-01-17 5 documents 52 findings

Areas cited

Aseptic processing and sterility assuranceEquipment and facilityLaboratory and QC controlsComplaint and recall handlingContamination controlDeviation, CAPA, and investigationTraining and personnelOther quality systemDocumentation and recordsLabeling and packaging

Published inspection documents

2024-01-17 US FDA 8 findingsLaboratory and QC controls · Training and personnel · Equipment and facility · Labeling and packaging · Aseptic processing and sterility assurance Laboratory contlols do not include the estab1ishmetJt of ·"-~'·'""'"''".,. 2024-01-17 US FDA 13 findingsContamination control · Other quality system · Aseptic processing and sterility assurance · Equipment and facility There is no data to support that the firm's processing procedures will not increase the risk of cross contamination between products. 2024-01-17 US FDA 11 findingsEquipment and facility · Deviation, CAPA, and investigation · Laboratory and QC controls · Contamination control · Complaint and recall handling · Aseptic processing and sterility assurance Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its intended use. 2024-01-17 US FDA 6 findingsAseptic processing and sterility assurance · Laboratory and QC controls · Deviation, CAPA, and investigation · Documentation and records Procedures designed to prevent microbiological contamination ofdrug products purporting to be sterile are not fully established and/or followed. 2024-01-17 US FDA 14 findingsAseptic processing and sterility assurance · Complaint and recall handling · Equipment and facility The firm's Quality Unit failed to identify, investigate, and implement permanent corrective actions after events that could impact the quality, safety, efficacy, and purity of sterile injectable drug products manufactured whether or not the batches has been already distributed.

About this page

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

What is included. As of 2026-09-03, only documents that have a detail page (at least 3 findings) are listed. The company may have more documents; the full set is available in Company lookup below.

Companies are grouped by a normalised key, not the displayed name — “… Limited” and “… Ltd.” count as the same company. Translation and classification are automated and may differ in nuance from the source; the basis for judgement is always the regulator's published document.

Full history of Central Admixture Pharmacy Services, Inc. (CAPS) — including inspection classifications Browse by document Go to Findings search